Business · 02/01/2018Updated: 10/17/2026 · 1 min read
FDA Corrects Notice on Withdrawal of 54 Abbreviated New Drug Applications
Summary
The FDA is correcting a notice that incorrectly announced the withdrawal of approval for 54 abbreviated new drug applications, including one for Chlorthalidone Tablets USP, 25 milligrams, held by Watson Laboratories, Inc., a subsidiary of Teva Pharmaceuticals USA, Inc.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →